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Introduction. Results on mitochondrial dysfunction in sepsis are controversial. We aimed to assess effects of LPS at wide dose and
time ranges on hepatocytes and isolated skeletal muscle mitochondria.Methods. Human hepatocellular carcinoma cells (HepG2)
were exposed to placebo or LPS (0.1, 1, and 10 𝜇g/mL) for 4, 8, 16, and 24 hours and primary human hepatocytes to 1 𝜇g/mL LPS
or placebo (4, 8, and 16 hours). Mitochondria from porcine skeletal muscle samples were exposed to increasing doses of LPS (0.1–
100 𝜇g/mg) for 2 and 4 hours. Respiration rates of intact and permeabilized cells and isolated mitochondria were measured by
high-resolution respirometry.Results. InHepG2 cells, LPS reducedmitochondrialmembrane potential and cellularATP content but
did not modify basal respiration. Stimulated complex II respiration was reduced time-dependently using 1𝜇g/mL LPS. In primary
human hepatocytes, stimulatedmitochondrial complex II respirationwas reduced time-dependently using 1𝜇g/mL LPS. In isolated
porcine skeletal muscle mitochondria, stimulated respiration decreased at high doses (50 and 100 𝜇g/mL LPS). Conclusion. LPS
reduced cellular ATP content of HepG2 cells, most likely as a result of the induced decrease in membrane potential. LPS decreased
cellular and isolated mitochondrial respiration in a time-dependent, dose-dependent and complex-dependent manner.
1. Introduction
Endotoxin or lipopolysaccharide (LPS) from the outer mem-
brane of Gram-negative bacteria is a trigger of the systemic
inflammatory response in sepsis [1]. Mitochondrial dysfunc-
tion has been postulated as a mechanism of cell injury and
reduced cellular ATP levels in sepsis [2–5]. Sepsis-induced
alterations in mitochondrial respiration may account for
the lactate production, intracellular acidosis, generation of
toxic radicals, and release of cytochrome c from damaged
mitochondria. A combination of these factorsmay contribute
to multiorgan failure syndrome in sepsis [6–8]. The effects
of LPS on mitochondrial function and, specifically, on mito-
chondrial respiration are controversial.
LPS triggersmacrophages via cell surface receptors (main-
ly TLR-4) to produce powerful inflammatory mediators
including tumor necrosis factor-alpha (TNF-𝛼), interleukin-
1𝛼 (IL-1𝛼), IL-1𝛽, and IL-6. The increased production of
these mediators is believed to be the direct cause of LPS
toxicity [1, 9–11]. Additionally, many studies demonstrated
uptake of LPS by cells [12–16]. Recently, LPS was proposed
to act intracellularly, independent of Toll-like receptor 4
[17, 18]. A study on rat cultured hepatocytes demonstrated
that LPS binds to the cell membrane and is found afterwards
in dispersed localization in the cytoplasm, reaching mito-
chondria [19]. Consecutively activated caspases might also
interact with mitochondria [20, 21]. In hepatocytes, caspase
1 activation reduced mitochondrial respiration and ROS
production by increasing mitochondrial autophagy [22].
Research on the effects of LPS on mitochondria has
been confounded by the wide range of doses and exposure
times. This has likely contributed to the heterogeneous and
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sometimes contradictory results [23]. Therefore, the aim of
the present study was to explore the dose response of LPS on
cellular respiration of cultured liver cells and isolated muscle
mitochondrial respiration.Hepatocyteswere used because (1)
liver failure is common in sepsis and (2) intra-abdominal
infections are among the main causes of severe sepsis and
septic shock [24]; in these circumstances the liver is the
first organ to be confronted with (high amounts of) LPS.
Muscle mitochondria were used because decreased muscle
mitochondrial enzyme activity and ATP content have been
reported in sepsis [25, 26]. We hypothesized that endotoxin
altersmitochondrial respiration in a dose-dependentway and
differently in liver compared to skeletal muscle tissue.
2. Materials and Methods
2.1. Chemicals and Reagents. LPS (TLR4 agonist, ultrapure E.
coli K12 lipopolysaccharide) was purchased from InvivoGen
(SanDiego, CA,USA). All the reagents for cellular respiration
were obtained from Sigma-Aldrich (Buchs, Switzerland).
2.2. Hepatoma Cell Line (HepG2) and Primary
Human Hepatocytes
2.2.1. Cell Culture. Human hepatocellular carcinoma cell
line (HepG2, Deutsche Sammlung von Mikroorganismen
und Zellkulturen (DSMZ), Braunschweig, Germany, N∘ACC
180) was cultured in 25 cm2 flasks (for respiration assays)
or 96-well plates (for determination of cellular ATP con-
tent and mitochondrial membrane potential) in RPMI 1640
culture medium containing 10% heat-inactivated fetal calf
serum (FCS), 1mM sodium pyruvate, 0.1mM nonessential
amino acids, 2mML-glutamine, 100 units/mL penicillin, and
100mg/mL streptomycin at 37∘C in a humid atmosphere
(5% CO
2
, 95% air). Cells were passaged upon reaching con-
fluence.
The primary human hepatocytes were kindly provided by
D. Stroka (University of Bern). Primary human hepatocytes
were isolated from wedges of resected liver tissues taken
from patients undergoing liver surgery. Written informed
consent was obtained prior to surgery in compliance with
the local ethical committee [27]. Cultures from 8 donors
were prepared and cultured according to Rencurel et al.
[28]. Additional primary human hepatocytes (5 donors) were
purchased from ScienCell Research Laboratories (Carlsbad,
CA, USA) and incubated with LPS and cell viability and
respiration rates of intact cells were analyzed.
2.2.2. Experimental Protocol. Quiescent cells were obtained
by total deprivation of FCS for 14 to 16 hours before the
experiments. All experiments were performed when cells
reached 90–95% confluency. On the day of experiment,
HepG2 was exposed to placebo or LPS (0.1, 1, 10𝜇g/mL)
for 4, 8, 16, and 24 hours. Primary human hepatocytes
were exposed to placebo or 1 𝜇g/mL LPS for 4, 8, and 16
hours. At the end of incubation times, cells were removed
by trypsinization, permeabilized, and used for mitochondrial
respiration. Due to the limited amount of primary human
hepatocytes, only 4, 8, and 16 hours of LPS exposure were
explored in these cell types.
2.2.3. Determination of Mitochondrial Respiration in Digi-
tonin-Permeabilized Cells. Respiration was determined as
described before [29]. After incubation, cells were trypsinized
and resuspended in RPMI-1640 with 10% FBS and then cen-
trifuged for 5min (350 g). Cell number and viability (using
the trypan blue method of dead-cell staining) were deter-
mined by the Countess automated cell counter (Invitrogen,
Eugene, OR, USA). Cells were resuspended in the respi-
ration buffer (110mM sucrose, 0.5mM EGTA, 3.0mM
MgCl2, 80mMKCl, 60mMK-lactobionate, 10mMKH2PO4,
20mM taurine, 20mM hepes, 1.0 g/L BSA, and pH 7.1.) at
a standard concentration of 1 × 106 cell/mL, and respira-
tion rates were measured at 37∘C in in 2mL glass chambers
using the high-resolution oxygraph (Oxygraph-2k, Oroboros
Instruments, Innsbruck, Austria). Mitochondrial complex
specific respiration rates were assessed by a standard titra-
tion protocol: first cells were permeabilized with digitonin
(8.1 𝜇M) for 5min. Afterwards, glutamate (10mM) and
malate (5mM), which provide nicotinamide adenine dinu-
cleotide (NADH) to the respiratory chain, were added (com-
plex I activation), followed by addition of ADP (0.25mM).
After a stable signal was reached and marked, rotenone
(0.5 𝜇M) was added to inhibit complex I and then complex
II-dependent respiration was stimulated by adding succi-
nate (10mM), which provides flavin adenine dinucleotide
(FADH) to the respiratory chain (complex II activation). After-
wards, complex III was inhibited by antimycin A (0.5 𝜇M),
and complex IV-dependent respiration was measured by
adding ascorbate (4mM) andN,N,N󸀠,N󸀠-tetramethyl-p-phe-
nylenediamine (TMPD, 0.5mM). Since TMPD exhibits a
wide range of autooxidation in the buffer, respiration was
finally inhibited with sodium azide (5mM), and the differ-
ence between oxygen consumption before and after addition
of sodium azide was interpreted as the real complex IV res-
piration.
2.2.4. Digitonin Titration. To confirm that mitochondrial
outer membrane integrity was not compromised in perme-
abilized cells, we performed digitonin titration to determine
the optimal concentration for permeabilization of HepG2
cells and primary human hepatocytes. For these experiments,
cells were suspended in respiration buffer (1 × 106 cells/mL)
and digitonin concentration was titrated in intact cells by
respirometry in the presence of 0.5mM rotenone (to inhibit
endogenous respiration of intact cells), 10mM succinate, and
1mM ADP. Respiration rates were measured at baseline and
after 2–5min after each titration. Respiration of intact HepG2
cells and primary hepatocytes was not stimulated in the pres-
ence of rotenone, succinate, and ADP. However subsequent
stepwise digitonin titration yielded gradual permeabilization
of plasma membranes, shown by the increase of respiration
up to full permeabilization. Permeabilization at a digitonin
concentration of 8–10𝜇M was optimum for ADP-stimulated
respiration.
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2.2.5. Coupled and Uncoupled Respiration of Intact Cells:
Cellular Respiration. After incubation with LPS (HepG2:
1 𝜇g/mL, 24 hours; primary human hepatocytes: 1𝜇g/mL, 24
hours), cells were trypsinised and resuspended in RPMI-
1640 with 10% FBS and then centrifuged for 5min (350 g).
Cells were resuspended in the respiration buffer (110mM
sucrose, 0.5mM EGTA, 3.0mMMgCl2, 80mM KCl, 60mM
K-lactobionate, 10mM KH2PO4, 20mM taurine, 20mM
hepes, 1.0 g/L BSA, and pH 7.1) at a concentration of 1 ×
10
6 cells/mL. Respiration rates were measured at 37∘C
using a high-resolution oxygraph (Oxygraph-2k, Oroboros
Instruments, Innsbruck, Austria). Basal coupled endogenous
respiration of intact cells (oxygen consumption without the
addition of exogenous substrate) was measured and recorded
using the linear rate of oxygen consumption. Afterwards,
oligomycin (an inhibitor of ATP synthase) (0.4 𝜇g/mL)
was added and the nonphosphorylating respiration rate
was measured (oligomycin-insensitive respiration). After-
wards the chemical uncoupler FCCP (carbonyl cyanide p-
trifluoromethoxyphenylhydrazone) was sequentially added
at different concentrations (0.1 to 0.5𝜇M) and maximal
uncoupled respiration was recorded. Thereafter, respiration
was inhibited with the addition of rotenone (0.5𝜇M) and
antimycin A (0.5𝜇M) and the remaining background respi-
ration was subtracted from all results.The uncoupled respira-
tory control ratio (uRCR) was calculated as the ratio between
the oxygen consumption rate in the presence of FCCP and the
rate in the presence of oligomycin. The oligomycin-sensitive
respiration (ATP turnover) was calculated by subtracting the
oligomycin-insensitive respiration from basal endogenous
respiration.The coupling efficiency corresponded to the ratio
of oligomycin-sensitive respiration rates by basal respiration
rates.
2.2.6. Measurement of Mitochondrial Membrane Potential
in Intact Cells. The mitochondrial electrochemical potential
gradient (Δ𝜓m) in intact cells was measured using the
cationic dye 5,5󸀠,6󸀠,6󸀠-tetrachloro-1,1󸀠,3,3󸀠-tetraethylbenzi-
midazolo-carbocyanine iodide (JC-1). JC-1 is amitochondrial
sensor which aggregates in polarized mitochondria, where
it forms red fluorescent aggregates. Dissipation of the mito-
chondrial membrane potential prevents the accumulation of
the JC-1 dye in the mitochondria, and the dye is dispersed
throughout the entire cell, leading to a shift from red (JC-
1 aggregates) to green fluorescence (JC-1 monomers). Thus
the loss of JC-1 aggregates directly correlates with changes in
Δ𝜓m. Briefly, for these experiments, the cells were grown in
96-well plates and treated with LPS for 24 hours (1 𝜇g/mL)
and the mitochondrial membrane potential was measured
using the JC-1 mitochondria staining kit for mitochondrial
potential change detection (Sigma, Switzerland) according to
the manufacturer’s instructions. Δ𝜓m was measured imme-
diately by fluorimetry. For JC-1 monomers, the fluorimeter
was set at a 490 nm excitation wavelength and 530 nm
emission wavelength and fluorescence wasmeasured. For JC-
1 aggregates, the fluorimeter was set at a 525 nm excitation
wavelength and 590 nm emission wavelength and fluores-
cence was measured. Afterwards, the Δ𝜓m (590/530 nm
fluorescence ratio) was calculated. Valinomycin (2.5𝜇g/mL)
was used as a positive control to depolarize themitochondrial
membrane potential.
2.2.7. Cytochrome c Test. In some additional experiments,
to evaluate the quality of the mitochondria, cytochrome
c test was performed to verify outer mitochondrial mem-
brane integrity. For these experiments, HepG2 and primary
human hepatocytes were incubated with LPS and perme-
abilized with digitonin (8.1 𝜇M) and mitochondrial outer
membrane integrity was tested bymeasurement ofmitochon-
drial respiration after the subsequent additions of glutamate
(10mM) and malate (5mM) and/or succinate (10mM), ADP
(0.25mM), and cytochrome c (10 𝜇M) followed by the addi-
tion of oligomycin (0.4 𝜇g/mL) to mimic state 4.
2.2.8. Measurement of the HepG2 Cells ATP Content. For
these experiments, the cells were grown in 96-well plates and
treated with LPS for 24 hours (1 𝜇g/mL). After treatment,
cells were lysed and exposed to the ATP substrate solution
using the Luminescent ATP Detection Assay Kit (Abcam,
Cambridge, USA) according to the manufacturer’s instruc-
tions and signal was measured on a luminescent counter.The
assay kit is a cellular ATP monitoring system based on firefly
(Photinus pyralis) luciferase and is based on the production
of light caused by the reaction of ATP with added luciferase
and D-luciferin. The emitted light is proportional to the
ATP concentration inside the cell. Valinomycin (2.5 𝜇g/mL)
was added to assess the effect of depolarized mitochondrial
membrane potential on ATP content.
2.2.9. Measurement of Release of Reactive Oxygen Species
(ROS) and Reactive Nitrogen Species (RNS). Cells were grown
in 96-well plates and treated with LPS for 24 hours (1 𝜇g/mL).
Total free radicals (ROS and RNS) levels were measured
in the supernatant using the OxiSelect In Vitro ROS/RNS
Assay Kit (Cell Biolabs Inc., San Diego, CA, USA). ROS
and RNS species react with DCFH to the fluorescent 2󸀠,7󸀠-
dichlorodihydrofluorescein (DCF). Its fluorescence intensity
is proportional to the total ROS and RNS levels within the
sample and was measured by fluorimetry.
2.3. Skeletal Muscle Mitochondria
2.3.1. Mitochondrial Isolation. Quadricepsmuscle biopsy was
taken from 7 anaesthetized pigs, from which mitochondria
were isolated by differential centrifugation as described by
Porta et al. [30]. Protein concentration was determined using
the Quant-itTM Protein Assay kit and read in QubitTM
fluorometer (Invitrogen, Basel, Switzerland). Pigs were used
afterwards for another experiment.The study was performed
in accordance with the National Institutes of Health guide-
lines for the care and use of experimental animals and with
the approval of the Animal Care Committee of the Canton
Bern, Switzerland.
2.3.2. Experimental Protocol. The protocol started immedi-
ately after isolation of the mitochondria, and determination
of respiration was finished within 6 hours in all groups.
Mitochondria from each biopsy sample were divided into 12
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Figure 1: Basal respiration of intact cells. HepG2 cells’ basal oxygen consumption, in the presence of oligomycin (leak respiration), and FCCP,
respectively, in LPS treated and control cells ((a); 𝑛 = 8 each). The uncoupled respiratory control ratio (uRCR) was calculated as the ratio
between the oxygen consumption rate in the presence of FCCP and the rate in the presence of oligomycin (b) and the coupling efficiency was
calculated as the ratio between oligomycin-sensitive and basal respiration rates (c). Data represented as box and whiskers (Tukey). Statistical
significance between samples was assessed using a Wilcoxon test. c: control; LPS: 1 𝜇g/mL LPS for 24 hours.
groups and incubated on ice with vehicle or 0.1, 1, 10, 50, and
100 𝜇g LPS/mg mitochondrial protein both for 2 hours and
for 4 hours. The different concentrations at 2 or 4 hours were
assessed in a randomized fashion. The data were compared
with its time-matched controls to prevent a time effect due to
a longer delay after isolation.
2.3.3. Determination of Mitochondrial Respiration in Isolated
Mitochondria. Mitochondrial respiration was performed as
described before [31]. Respiratory rates were determined at
a final mitochondrial protein concentration of 0.4mg/mL in
the above-described respiration buffer. Respiration was mea-
sured at 37∘C in 2mL glass chambers using the high-resolu-
tion oxygraph (Oxygraph-2k, Oroboros Instruments, Inns-
bruck, Austria). Each complex was assessed with a separate
mitochondrial sample. Maximal oxidative capacities (state 3)
were determined in the presence of oxygen content of room
air (21%). For complex I-dependent respiration, substrates
were glutamate (10mM) + malate (5mM) followed by ADP
(0.025mM). For measurement of complex II-dependent
respiration, succinate (10mM) and ADP (0.025mM) were
added. The coupling of phosphorylation to oxidation was
determined by calculating the respiratory control ratio (RCR)
as the ratio between ADP-stimulated respiration (state 3)
and respiration after ADP depletion (state 4). Complex
IV-dependent respiration was measured by adding ascor-
bate (4mM), N,N,N󸀠,N󸀠-tetramethyl-p-phenylenediamine
(TMPD, 0.5mM) and ADP (0.025mM). Since TMPD
exhibits a wide range of autooxidation in the buffer, respi-
ration was finally inhibited with sodium azide (5mM), and
the difference between the oxygen consumption before and
after the addition of sodium azide was interpreted as the
real complex IV respiration. Respiration rates were calculated
as the time derivative of oxygen concentration measured
in the closed respirometer and expressed per million viable
cells. The amplified signal was recorded in a computer
with online display of the calibrated oxygen concentration
and oxygen flux (DatLab software for data acquisition and
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Figure 2: ATP content and mitochondrial membrane potential of intact cells. (a) Cellular ATP content of HepG2 was determined after 24
hours exposure with 1𝜇g/mL LPS (𝑛 = 90), control (𝑛 = 102), valinomycin (2.5 𝜇g/mL) for 24 h (𝑛 = 12), and valinomycin for 20minutes (𝑛 =
12). Kruskal-Wallis 𝑃 < 0.0001. (b) Mitochondrial membrane potential measured by the changes in the 590/530 JC-1 emitted fluorescence.
Control: 𝑛 = 30, LPS: 𝑛 = 24. Valinomycin (2.5 𝜇g/mL; incubation for 20 minutes) served as a positive control, to depolarize mitochondrial
membrane potential (𝑛 = 6). Data are represented as box and whiskers (Tukey). Groups were compared using Mann-Whitney 𝑈 test (two
groups) or Kruskal-Wallis test followed by Dunn’s correction of multiple comparisons (three groups). (c: control; LPS: lipopolysaccharide;
val: valinomycin.)
analysis; Oroboros Instruments, Innsbruck, Austria). Oxygen
consumption is expressed as pmol O
2
/s/mg of mitochondrial
protein.
2.4. Statistics. Statistical analysis was performed with the
SPSS software package (SPSS 15.0, SPSS Inc., Chicago, IL) and
Prism 6 (GraphPad Software, La Jolla, CA). Mitochondrial
respiration of each complex at different doses of LPS was
compared at each time point using the nonparametric Fried-
man test followed by the Dunn’s test for multiple compar-
isons. If significant, the Wilcoxon test was used to compare
this dose with its control. For primary human hepatocytes,
the Wilcoxon test was used as only one dose of LPS was
explored, due to the limited availability of primary human
hepatocytes. For unpaired data (ATP content, mitochondrial
membrane potential) the Mann-Whitney test was used. Data
are shown as median and interquartile range (IQR).
3. Results
3.1. Hepatoma Cell Line (HepG2). For the measurement of
cellular respiration of intact cells, cells were exposed to LPS
and respiration rates were measured in the absence of exo-
genous substrates and ADP. LPS at 1 𝜇g/mL for 24 hours
did not affect basal endogenous cellular respiration of intact
cells, oligomycin-insensitive (nonphosphorylating respira-
tion), oligomycin-sensitive (ATP turnover), and FCCP-
uncoupled maximal respiration rates (Figure 1(a)). Neither
uncoupled respiratory control ratio (the ratio between FCCP
and oligomycin-insensitive respiration rates) nor coupling
efficiency (the ratio between oligomycin-sensitive and basal
respiration rates) were affected (Figure 1(b)). LPS did not
affect cellular viability (median, IQR: 89% (85%–90%) live
cells in controls versus 88% (86%–90%), in stimulated cells).
LPS at 1 𝜇g/mL for 24 hours decreased cellular ATP
content and mitochondrial membrane potential in intact
cells (Figure 2). Valinomycin, which was used as a positive
control and is known to depolarize mitochondrial membrane
potential, did induce a significant decrease in mitochondrial
membrane potential and cellular ATP content (Figure 2). LPS
did not alter reactive oxygen species (ROS) and reactive
nitrogen species (RNS) concentration in the cell culture
medium (Figure 3).
Representative respiration rates of permeabilized HepG2
cells using high-resolution respirometry are shown in Figure
4 (𝑛 = 10 for each experiment). 24 hours of incubation
with LPS (1𝜇g/mL) induced a significant reduction in max-
imal complex II-dependent and IV-dependent respiration of
HepG2 cells but did not affect cell viability (Table 1). 0.1 and
10 𝜇g LPS/mL as well as 4, 8, and 16 hours of incubation
induced no significant changes.
3.2. Isolated Primary Human Hepatocytes. Basal respiration
rates were determined in intact primary human hepatocytes
in the absence of exogenous substrates (Figure 5).There were
no significant differences after exposure to 1 𝜇g/mL LPS (8
hours incubation).
1 𝜇g/mL LPS reduced complex II-dependent but not
complex I-dependent or complex IV-dependent respiration
of isolated and permeabilized human hepatocytes after 8
hours incubation (𝑃 = 0.016; Table 2). LPS did not affect
viability of isolated primary human hepatocytes (Table 2).
3.2.1. Cytochrome c. Cytochrome c did not enhance respi-
ration of the HepG2 or primary human hepatocytes treated
with placebo or LPS indicating that there was no loss of
6 BioMed Research International
D
CF
 (p
m
ol
/𝜇
g 
ce
llu
la
r p
ro
te
in
)
Total ROS and RNS levels0.4
0.2
0.3
0.0
0.1
c LPS
∗∗
Figure 3: Measurements of total free radical ROS and RNS levels in supernatants of intact cells. Total reactive oxygen species (ROS) and
reactive nitrogen species (RNS) were determined after reaction with DCFH to DCF (2󸀠,7󸀠-dichlorodihydrofluorescein) in supernatants of
LPS treated and control cells (𝑁 = 16 each). The fluorescence of DCF is proportional to the content of ROS and RNS in the cell culture
medium. DCF was expressed per pmol DCF/𝜇g cellular protein. Data are represented as box and whiskers (Tukey). Groups were compared
using Mann-Whitney 𝑈 test. ∗∗𝑃 = 0.0052.
240
180
120
60
0
240
180
120
60
0
250
200
150
100
50
0
250
200
150
100
50
0
01 02 03 04 05
gm
succ
aa asctmpd
G
M
A
D
P
RO
T
SU
C
A
A A
SC
 T
M
PD
S3 S3
S3
N
aN
3
Range [h:min]: 0:30 
Range [h:min]: 0:30 01 02 03 04 05
gm
succ
aa asctmpd
S3 S3
S3
O
2
co
nc
en
tr
at
io
n 
(A
) (
nm
ol
/m
L)
O
2
co
nc
en
tr
at
io
n 
(A
) (
nm
ol
/m
L)
O
2
ﬂo
w
 p
er
 ce
lls
 (A
) 
adp rot Stop
adp rot Stop
NaN3
NaN3
0:50
0:50
0:55
0:55
1:00
1:00
1:05
1:05
1:10
1:10
1:15
1:15
1:20
1:20
(p
m
ol
/s
∗
m
ill
io
n)
O
2
ﬂo
w
 p
er
 ce
lls
 (A
) 
(p
m
ol
/s
∗
m
ill
io
n)
Complex I Complex II Complex IV
Figure 4: Tracings from the OROBOROS-high-resolution respirometry of permeabilized cells. Legend: the upper tracing represents a cell
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3
: sodium azide, and S3: state 3. State
4 cannot be measured due to the saturating concentration of ADP during the experiment.
BioMed Research International 7
Table 1: Effects of LPS exposure on cellular respiration and cell viability of cultured, digitonin-permeabilized human hepatoma cells (HepG2)
for various time intervals and at different concentrations. For cellular respiration, all values are expressed as pmol O2/(sec ∗ Mill. Cells);
∗∗
𝑃 < 0.01; 𝑛 = 10 each (LPS treated and control cells); data are expressed as median (IQR). Friedman test followed by Dunn’s correction
of mutliple comparisons was used to detect differences between doses of LPS at each time point. If significant, a Wilcoxon test was used to
compare the difference compared to the corresponding control group. Wilcoxon of complex II 24 hours 1𝜇g LPS/mL versus control: 𝑃 =
0.002; Wilcoxon of complex IV 24 hours 1 𝜇g LPS/mL versus control: 𝑃 = 0.004.
HepG2 permeabilized Control 0.1 𝜇g LPS/mL 1 𝜇g LPS/mL 10 𝜇g LPS/mL Friedman 𝑃
Complex I
4 h 99 (86–112) 107 (88–115) 105 (101–111) 106 (98–119) 0.430
8 h 90 (78–99) 89 (77–105) 89 (82–96) 88 (76–95) 0.392
16 h 95 (68–101) 96 (83–106) 95 (84–101) 89 (81–99) 0.472
24 h 96 (82–110) 105 (92–111) 87 (84–97) 91 (77–110) 0.339
Complex II
4 h 121 (107–126) 115 (108–134) 123 (109–127) 124 (114–130) 0.516
8 h 126 (109–135) 117 (95–133) 131 (118–145) 125 (99–135) 0.339
16 h 104 (81–129) 120 (91–132) 115 (95–126) 108 (95–126) 0.669
24 h 94 (78–111) 94 (84–105) ∗∗76 (68–93) 84 (67–99) 0.006
Complex IV
4 h 172 (166–187) 179 (155–210) 170 (166–181) 174 (161–185) 0.669
8 h 166 (97–200) 144 (118–166) 145 (126–168) 147 (129–173) 0.840
16 h 139 (90–171) 127 (108–165) 123 (111–156) 122 (109–174) 0.840
24 h 98 (90–130) 99 (84–118) ∗∗81 (63–93) 98 (89–133) 0.007
Viability (%)
8 h 84 (68–91) 87 (72–95) 88 (71–93) 88 (70–92)
16 h 95 (93–96) 93 (90–94) 94 (91–95) 94 (90–95)
24 h 94 (92–95) 92 (89–93) 94 (93–95) 93 (90–95)
Table 2: Time course of 1 𝜇g/mL LPS on oxygen consumption and cell viability of isolated and permeabilized human hepatocytes. 8 hours of
incubation with 1𝜇g/mL LPS reduces complex II-dependent respiration compared to control (∗𝑃 = 0.03). For cellular oxygen consumption,
all values are expressed as pmol O2/(sec ∗Mill. Cells). AWilcoxon test for non-parametric paired data was used to compare the control group
with the LPS group at each time point.𝑁 = 8 for 4 and 16 hours, 𝑛 = 7 for 8 hours in LPS treated and control cells.
Primary hepatocytes permeabilized Control 1 𝜇g LPS/mL 𝑛 𝑃
Complex I
4 h 252 (91–351) 287 (116–337) 8 0.547
8 h 248 (93–340) 198 (88–293) 7 0.156
16 h 191 (112–368) 172 (113–329) 8 0.641
Complex II
4 h 411 (198–474) 342 (201–510) 8 0.844
8 h 454 (242–523) ∗365 (167–511) 7 0.016
16 h 317 (239–530) 274 (241–516) 8 0.742
Complex IV
4 h 242 (192–308) 256 (146–346) 8 0.641
8 h 257 (167–350) 203 (143–383) 7 0.375
16 h 287 (208–362) 308 (179–388) 8 0.844
Viability (%)
control 98 (93–99) 5
4 h 91 (83–95) 5
8 h 99 (99-100) 5
16 h 97 (93–99) 5
cytochrome c from mitochondrial outer membrane and
mitochondrial integrity was preserved (data not shown).
3.3. IsolatedMitochondria. Control mitochondria kept on ice
for 4 hours were significantly lower compared to the same
mitochondria analyzed 2 hours after isolation. To prevent the
time effect, each exposed sample of mitochondria was com-
pared to its time-matched control sample. Two-hour incu-
bation with 50 and 100𝜇g LPS/mg mitochondrial protein
reduced complex I state 3, complex I state 4, and complex II
state 3 dependent mitochondrial oxygen consumption (Table
3).
4. Discussion
LPS did not impair basal respiration in intact HepG2
cells. Despite maintained oxygen consumption, cellular ATP
content was reduced, likely as a result of the induced reduc-
tion of the mitochondrial membrane potential. The effects
were similar, albeit less strong, than those of valinomycin, an
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Figure 5: Basal respiration of intact cells. Primary human hepatocytes’ basal oxygen consumption, in the presence of oligomycin (leak
respiration), and FCCP, respectively, in LPS treated and control cells ((a); 𝑛 = 5 each). The uncoupled respiratory control ratio (uRCR)
was calculated as the ratio between the oxygen consumption rate in the presence of FCCP and the rate in the presence of oligomycin (b) and
the coupling efficiency was calculated as the ratio between oligomycin-sensitive and basal respiration rates (c). Data represented as box and
whiskers. Statistical significance between samples was assessed using a Wilcoxon test. c: control; lps: 1 𝜇g/mL LPS for 8 hours.
ionophore capable of depolarizingmitochondria [32]. Others
confirmed the mitochondrial potential lowering characteris-
tics of LPS in hepatocytes [33–35]. LPSmay cause recruitment
of an uncoupling protein (UCP2) both in vivo and in vitro
and thereby decrease the mitochondrial membrane potential
[34]. LPS can also induce ROS production and loss of
mitochondrial membrane potential by TNF-𝛼 and IFN-𝛾
upregulation via iNOS induction and NO production [35].
Mitochondrial oxygen consumption was only affected
by LPS when respiration was stimulated with complex
specific substrates (e.g., succinate for complex II). In primary
human hepatocytes LPS induced a reduction in complex
II-dependent respiration rates. Due to the limited availability
of primary human hepatocytes, we evaluated further effects
of LPS in HepG2 cells, a human hepatoma cell line. Also
in HepG2 cells, LPS reduced stimulated respiration. Finally,
maximal respiration was also impaired in isolated skeletal
muscle mitochondria.
Our data confirm the findings of a previous review on
effects of sepsis on mitochondrial functions and may explain
the heterogenous results in the literature: LPS effects seem
to be time, dose, tissue, and method dependent. We found
impaired respiration after 8 hrs (human hepatocytes) or only
after 24 hrs of LPS incubation (HepG2 cells) and at 1𝜇g
LPS/mL (hepatocytes) or at only 50 and 100 𝜇g LPS/mL (iso-
lated skeletal mitochondria). Furthermore, mitochondrial
complexes I, II, or IV could be implicated alone or in var-
ious combinations. Finally, we demonstrate that immediate
processing of tissue samples is crucial for detection of LPS
effects. This is especially important when time-consuming
procedures like differential centrifugation are involved.
Transient effects of LPS on primary hepatocytes’ mito-
chondrial respiration have been reported previously [33]. In
a former experimental series, we have also reported transient
effects of TLR-3 stimulation on HepG2 and postulated
mitochondrial biogenesis to be involved in mitochondrial
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recovery [29]. New insights to this phenomenon come from a
recently published article: it was proposed that, in reaction to
LPS or sepsis, mitochondrial oxygen consumption is reduced
as a protective mechanism to prevent cell death [33]. During
recovery, the cell may get rid of dysfunctional mitochondria
by autophagy and seems to activate mitochondrial biogenesis
via TLR-9 stimulation in autophagosomes, which could lead
finally to a restored function of mitochondria [33].
LPS is recognized by TLR4, which is present not only on
the surface of immune cells but also on the surface of hepa-
tocytes [1, 36, 37], including HepG2 cells [38, 39]. However,
their density on the cell surface may vary.The binding of LPS
on TLR4 activates complex intracellular pathways leading to
the activation of transcription factors like NF𝜅B, which then
results in the release of mediators of the immune system [40].
TLR1/2/4 signaling drives mitochondria in macrophages to
increase reactive oxygen species (ROS) production in res-
ponse to bacteria [41]. West et al. suggested a direct signaling
pathway that links TLR’s with mitochondria [41]. In HepG2
cells in the present study ROS and RNS levels were not
increased after 24 h exposure to LPS. It has been described
that the increase in ROS is transient [42], and we may have
missed the peak in our study.
In addition to a TLR4mediated pathway, a mechanism of
LPS endocytosis is postulated and it has been shown that LPS
can reach mitochondria directly [12–16, 19]. Therefore, we
evaluated the effect of increasing LPS doses at different expo-
sure times on isolated skeletal muscle mitochondria from
healthy pigs. We observed impaired mitochondrial respi-
ration only at high LPS doses. We did not observe any
effect on respiratory control ratio (RCR) of isolated muscle
mitochondria because of the simultaneous decrease of state
3 and state 4. However, others found a reduced RCR after
exposure of isolatedmitochondria to LPS, either by a decrease
in state 3 or by an increase in state 4 [43, 44].Themechanism
of a direct LPS effect onmitochondria is not well understood.
Recently, TLR-4 independent activation of caspase 11 by
intracellular LPSwas proposed, which could lead to either IL-
1 activation or cell death [17, 18]. The intermediates or recep-
tors for intracellular LPS are not known. Furthermore, there
are reports about intracellular TLR4 receptors in macro-
phages and human coronary artery endothelia cells, which
react to LPS stimuli [45, 46]. But till now, there is no evidence
of any interaction of intracellular TLR4 and mitochondria.
Therefore, it is not known how LPS induces isolated mito-
chondrial dysfunction directly.
In HepG2 and primary human hepatocytes, LPS
decreased cellular respiration in the presence of exogenous
substrates (permeabilized cells) without impairing basal res-
piration of intact cells. A limitation of the present study is
that most of the cellular experiments were performed in
HepG2 cells, due to the limited availability of primary human
hepatocytes. HepG2, a human hepatoma cell line, has a differ-
ent phenotype compared to primary hepatocytes and is
thought to be a mature epithelial cell line, which can form
structures similar to bile canaliculi [47]. HepG2 has a lower
rate of triglycerides secretion than primary hepatocytes and
resembles more fasted primary hepatocytes [47]. Further-
more, HepG2 has very low levels of functional cytochrome
P450 enzymes compared to primary hepatocytes [48]. How-
ever, HepG2 contains a high level of mitochondria and
mtDNA and is therefore a good model to investigate mito-
chondrial toxicity [49]. It should be noted that HepG2 cells
as cancer cells have distinct metabolism involving oxidative
glutaminolysis (nonexisting in primary noncancerous hepa-
tocytes) and their ability to switch between aerobic glycoly-
sis and andoxidative phosphorylation, thus varying contribu-
tion of these two to overall ATP.This is in contrast to primary
hepatocytes in which 99% ATP originates from oxidative
phosphorylation. Permeabilizationmay on one hand equalize
these distinctions, but not the different enzyme composi-
tion pattern of HepG2 cells versus primary hepatocytes.
Limitations in the use of primary human hepatocytes are
their limited availability, instability in vitro, and substantial
variability if derived from different donors [48].
5. Conclusion
LPS decreased mitochondrial membrane potential and cel-
lular ATP content in intact HepG2 cells without impairing
basal respiration. However, maximal (stimulated) respiration
was decreased in the presence of exogenous substrates (per-
meabilized cells) in a time-dependent and dose-dependent
fashion. In primary hepatocytes, LPS decreased as well as
cellular respiration in the presence of exogenous substrates
(permeabilized cells) without impairing basal respiration.
Our data confirm the heterogeneous reaction of mito-
chondrial respiration to LPS.
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